Researchers at the University of Montreal found that people over the age of 50 who recovered from a mild case of Covid-19 had more antibodies against the virus than younger people.
Lomecel-B – Longeveron’s proprietary off-the-shelf cell therapy for aging frailty – failed the six-minute walk test (6MWT) endpoint of a Phase IIb study, according to a statement published by the Miami-based biotech on Aug. 13.
A study published in the journal eLife of 81 semi-supercentenarians—people 105 years of age or older—and supercentenarians—110 years or older from across Italy, were analyzed by researchers from the University of Bologna, Italy and Nestle Research in Lausanne, Switzerland. Researchers compared genetic data from these extraordinary agers to 36 healthy people from the same region whose age, on average, was 68 years.
Researchers from Aarhus University in Denmark published research indicating that Parkinson’s disease is actually two types of the disease.
San Francisco-based Unity Biotechnology launched a restructuring program to focus on cellular senescence in ophthalmology and neurology.
A study published in the journal Cell Stem Cell revealed how aging can cause lung regeneration to go awry, which can potentially lead to lung cancer and other diseases.
Recently published scientific studies include research into whether Covid-19 immunity might not be possible.
Little headway has been made in developing a treatment for Alzheimer’s disease, but that could be changing.
First-time marathon runners can add years to their lives and reap the health rewards of lower blood pressure and healthier arteries, even if they take on the challenge in mid-to-later life, research showed.
People who get even a small amount of exercise may be less likely to die prematurely than their more sedentary counterparts, a research review suggests.